SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

Infinity Pharmaceuticals Q1 EPS $(0.190) Misses $(0.130) Estimate

Infinity Pharmaceuticals (NASDAQ:INFI) reported quarterly losses of $(0.190) per share which missed the analyst consensus estimate of $(0.130) by 46.15 percent. This is a 20.83 percent increase over losses of $(0.240)

Benzinga · 05/11/2020 11:36

Infinity Pharmaceuticals (NASDAQ:INFI) reported quarterly losses of $(0.190) per share which missed the analyst consensus estimate of $(0.130) by 46.15 percent. This is a 20.83 percent increase over losses of $(0.240) per share from the same period last year.